Literature DB >> 19969381

Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD).

Marcello Giordano1, Ligia J Dominguez, Teresa Vitrano, Massimiliano Curatolo, Anna Ferlisi, Anna Di Prima, Mario Belvedere, Mario Barbagallo.   

Abstract

Acetylcholinesterase inhibitors (AchEIs) are extensively used in Alzheimer's disease (AD) while reality orientation therapy (ROT) is a cognitive rehabilitation indicated for mentally deteriorated patients. We aimed to evaluate the efficacy of the combination of donepezil with an intensive ROT with active participation of the caregiver. Patients with AD (n=100, mean age 78.4±4.3 years) initiated treatment with donepezil, 5mg/day; 62 of them underwent a 3-week, daily ROT and physical reactivation training with the caregiver (Group A); 38 participants received only donepezil therapy (Group B). All subjects were tested for cognitive and functional abilities at baseline, at the end of the training program, and after 2 months of follow-up. There was a significant improvement in mini-mental state examination (MMSE) score (p<0.001) and the AD assessment scale-cognitive (ADAS-Cog) subscale (p<0.001), without changes in impaired activity of daily living (ADL) and instrumental ADL (IADL) after intensive ROT training in Group A. MMSE was maintained after 2 months in-home ROT continuation. There were no significant changes in MMSE in drug-only treated patients (Group B) after 3 weeks, with a non-significant tendency to improvement in ADAS-Cog. Our results suggest benefit of an intensive ROT program in dementia patients receiving donepezil that seems to be maintained as far as ROT is continued by the caregiver.
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19969381     DOI: 10.1016/j.archger.2009.11.008

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  12 in total

Review 1.  Cognitive reserve and Alzheimer's disease.

Authors:  Wei Xu; Jin-Tai Yu; Meng-Shan Tan; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-05-04       Impact factor: 5.590

Review 2.  Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascular dementia.

Authors:  Alex Bahar-Fuchs; Linda Clare; Bob Woods
Journal:  Cochrane Database Syst Rev       Date:  2013-06-05

Review 3.  Cognitive intervention in Alzheimer disease.

Authors:  Verena Buschert; Arun L W Bokde; Harald Hampel
Journal:  Nat Rev Neurol       Date:  2010-08-17       Impact factor: 42.937

4.  Cognitive training for people with mild to moderate dementia.

Authors:  Alex Bahar-Fuchs; Anthony Martyr; Anita My Goh; Julieta Sabates; Linda Clare
Journal:  Cochrane Database Syst Rev       Date:  2019-03-25

5.  Patients with moderate Alzheimer's disease engage in verbal reminiscence with the support of a computer-aided program: a pilot study.

Authors:  Giulio E Lancioni; Nirbhay N Singh; Mark F O'Reilly; Jeff Sigafoos; Fiora D'Amico; Gabriele Ferlisi; Floriana Denitto; Floriana De Vanna; Marta Olivetti Belardinelli
Journal:  Front Aging Neurosci       Date:  2015-06-03       Impact factor: 5.750

6.  Donepezil can improve daily activities and promote rehabilitation for severe Alzheimer's patients in long-term care health facilities.

Authors:  Kenichi Meguro; Yoshitaka Ouchi; Kyoko Akanuma; Mitsue Meguro; Mari Kasai
Journal:  BMC Neurol       Date:  2014-12-17       Impact factor: 2.474

7.  Are the effects of a non-drug multimodal activation therapy of dementia sustainable? Follow-up study 10 months after completion of a randomised controlled trial.

Authors:  Katharina Luttenberger; Benjamin Hofner; Elmar Graessel
Journal:  BMC Neurol       Date:  2012-12-05       Impact factor: 2.474

Review 8.  Cognitive training and cognitive rehabilitation for persons with mild to moderate dementia of the Alzheimer's or vascular type: a review.

Authors:  Alex Bahar-Fuchs; Linda Clare; Bob Woods
Journal:  Alzheimers Res Ther       Date:  2013-08-07       Impact factor: 6.982

Review 9.  Methodological considerations regarding cognitive interventions in dementia.

Authors:  Agustín Ibanez; Pablo Richly; María Roca; Facundo Manes
Journal:  Front Aging Neurosci       Date:  2014-08-13       Impact factor: 5.750

10.  Technology-Aided Programs to Support Positive Verbal and Physical Engagement in Persons with Moderate or Severe Alzheimer's Disease.

Authors:  Giulio E Lancioni; Nirbhay N Singh; Mark F O'Reilly; Jeff Sigafoos; Fiora D'Amico; Caterina Renna; Katia Pinto
Journal:  Front Aging Neurosci       Date:  2016-04-21       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.